XIAOMI-W
01810
MEITUAN-W
03690
NTES-S
09999
TRIP.COM-S
09961
TENCENT
00700
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|
Cash flow from operating activities | ||||
Earning before tax | -98.73%13.84M | -0.05%1.09B | 490.29%1.09B | --184.03M |
Profit adjustment | ||||
Interest (income) - adjustment | -108.76%-48.39M | -6,286.23%-23.18M | -29.18%-363K | ---281K |
Attributable subsidiary (profit) loss | 88.81%-995K | 54.00%-8.89M | -2,737.00%-19.32M | ---681K |
Impairment and provisions: | ---- | --6.11M | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | --6.11M | ---- | ---- |
Asset sale loss (gain): | -116.24%-35.31M | -122.42%-16.33M | -8,257.78%-7.34M | --90K |
-Loss (gain) from sale of subsidiary company | ---- | --1.47M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | 42.98%-10.15M | -142.48%-17.8M | -8,257.78%-7.34M | --90K |
-Loss (gain) from selling other assets | ---25.16M | ---- | ---- | ---- |
Depreciation and amortization: | -12.30%207.74M | 92.18%236.88M | 233.76%123.26M | --36.93M |
-Depreciation | -12.30%207.74M | 92.18%236.88M | 233.76%123.26M | --36.93M |
Financial expense | -53.00%4.03M | 104.88%8.56M | 32.28%4.18M | --3.16M |
Exchange Loss (gain) | -24.70%497K | -60.46%660K | 303.14%1.67M | --414K |
Special items | --3.1M | ---- | ---- | ---- |
Operating profit before the change of operating capital | -88.80%144.49M | 8.52%1.29B | 431.33%1.19B | --223.66M |
Change of operating capital | ||||
Inventory (increase) decrease | 24,885.71%3.5M | 100.09%14K | -1,501.50%-14.91M | ---931K |
Accounts receivable (increase)decrease | -68.60%27.46M | 241.59%87.44M | -10.53%-61.76M | ---55.87M |
Accounts payable increase (decrease) | -136.64%-53.71M | -126.82%-22.7M | 115.78%84.62M | --39.22M |
Special items for working capital changes | -71.33%8.08M | 211.11%28.19M | -185.37%-25.37M | ---8.89M |
Cash from business operations | -90.61%129.83M | 18.07%1.38B | 493.86%1.17B | --197.18M |
Other taxs | 90.42%-825K | -1,776.03%-8.61M | -179.88%-459K | ---164K |
Net cash from operations | -90.61%129M | 17.38%1.37B | 494.12%1.17B | --197.01M |
Cash flow from investment activities | ||||
Interest received - investment | 108.76%48.39M | 6,286.23%23.18M | 29.18%363K | --281K |
Sale of fixed assets | 16.16%20.83M | 142.49%17.93M | 5,070.63%7.39M | --143K |
Purchase of fixed assets | -65.92%-395.75M | 50.21%-238.52M | -425.35%-479.04M | ---91.18M |
Purchase of intangible assets | -539.17%-767K | ---120K | ---- | ---3K |
Sale of subsidiaries | ---- | --21.64M | ---- | ---- |
Recovery of cash from investments | --157.3M | ---- | ---- | ---- |
Net cash from investment operations | 3.35%-169.99M | 62.68%-175.88M | -419.24%-471.28M | ---90.76M |
Net cash before financing | -103.42%-40.99M | 71.34%1.2B | 558.08%699.21M | --106.25M |
Cash flow from financing activities | ||||
New borrowing | ---- | ---- | 60.86%111.77M | --69.48M |
Refund | ---- | -615.06%-191.79M | 56.73%-26.82M | ---61.98M |
Interest paid - financing | 53.00%-4.03M | -104.88%-8.56M | -32.28%-4.18M | ---3.16M |
Dividends paid - financing | -8.11%-400M | -3,438.98%-370M | -198.71%-10.46M | ---3.5M |
Net cash from financing operations | 24.42%-562.87M | -61,912.32%-744.77M | 92.74%-1.2M | ---16.54M |
Effect of rate | 105.47%68K | 74.87%-1.24M | -354.95%-4.95M | --1.94M |
Net Cash | -233.22%-603.86M | -35.06%453.29M | 678.09%698.01M | --89.71M |
Begining period cash | 52.07%1.32B | 395.98%868.09M | 109.92%175.03M | --83.38M |
Cash at the end | -45.74%716.34M | 52.07%1.32B | 395.98%868.09M | --175.03M |
Cash balance analysis | ||||
Currency Unit | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | KPMG | KPMG | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.